Zagazig University Digital Repository
Home
Thesis & Publications
All Contents
Publications
Thesis
Graduation Projects
Research Area
Research Area Reports
Search by Research Area
Universities Thesis
ACADEMIC Links
ACADEMIC RESEARCH
Zagazig University Authors
Africa Research Statistics
Google Scholar
Research Gate
Researcher ID
CrossRef
Co-administration of ketoconazole and tacrolimus therapy: A transplanted rat model
Faculty
Veterinary Medicine
Year:
2005
Type of Publication:
Article
Pages:
633-639
Authors:
Barakat, Nashwa, Abdel-Maboud, Mahmoud, El-shair, Mahasen A, Sabry, Alaa, El-Agroudy, Amgad, Hawas, Samia, Ghoneim, M. A
DOI:
10.1007/s11255-005-2393-4
Journal:
INTERNATIONAL UROLOGY AND NEPHROLOGY SPRINGER
Volume:
37
Research Area:
Urology \& Nephrology
ISSN
ISI:000202943700041
Keywords :
ketoconazole, FK506, experimental, tacrolimus
Abstract:
Background/Aim: The aim of this work is to study the safety and the effect of addition of ketoconazole to experimental kidney transplanted rat treated with tacrolimus and predicts the percentage of tacrolimus dose reduction. Material and Methods: The material of this work included 60 male Sprague Dawely rats subjected to renal allotransplantation. They were equally divided into five groups: Group I: served as control group, Group II: received FK506 3.2 mg/kg/bw, Group III: received FK506 2 mg/kg/bw, Group IV: received FK506 1 mg/kg/bw, Group V: received FK506 1 mg/kg/bw plus Ketoconazole 20 mg/ kg/day. FK506 trough level and laboratory investigations were determined at 0, 3, 7, 10, 14, and 27 days post-transplantation. Results: In all groups loss of body weight was observed at day 27 after treatment compared to that before transplantation. Serum creatinine significantly increased at day 27 compared to the basal level in groups treated with 1.0 and 3.2 mg FK506 (1.80 +/- 0.50 versus 0.39 +/- 0.06 P=0.001) and (1.03 +/- 0.26 versus 0.50 +/- 0.07 P=0.001) respectively, while for 2.0 mg or 1.0 mg plus keto groups, no significant differences in serum creatinine levels over time (0.56 +/- 0.22 versus 0.44 +/- 0.10 P=0.106) and (0.55 +/- 0.30 versus 0.42 +/- 0.08 P=0.160) were observed. Conclusion: Concomitant administration of Ketoconazole and FK506 in transplanted rat model is safe and results in increase of blood trough level concentration of FK506 with 50\% reduction of its dose.
Online
PDF
جامعة المنصورة
جامعة الاسكندرية
جامعة القاهرة
جامعة سوهاج
جامعة الفيوم
جامعة بنها
جامعة دمياط
جامعة بورسعيد
جامعة حلوان
جامعة السويس
شراقوة
جامعة المنيا
جامعة دمنهور
جامعة المنوفية
جامعة أسوان
جامعة جنوب الوادى
جامعة قناة السويس
جامعة عين شمس
جامعة أسيوط
جامعة كفر الشيخ
جامعة السادات
جامعة طنطا
جامعة بنى سويف